GSK5533524
300163
Phase 1 small_molecule active
Quick answer
GSK5533524 for Neoplasms is a Phase 1 program (small_molecule) at GlaxoSmithKline with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline
- Indication
- Neoplasms
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active